The global childhood absence epilepsy treatment market was valued at US$ 158.2 million in 2017 and is expected to witness a robust CAGR of 5.4% over the forecast period (2018 – 2026).
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients